T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
JB Hunt Transport Services
JBHT
$26.5B
| $415M | 0.05% |
2,083,558
-78,646
| -4% | -$15.9M |
|
302
Zebra Technologies
ZBRA
$17.9B
| $414M | 0.05% |
1,373,792
+425,207
| +45% | +$114M |
|
303
RenaissanceRe
RNR
$13.3B
| $412M | 0.05% |
1,751,933
-77,055
| -4% | -$17.1M |
|
304
AT&T
T
$167B
| $412M | 0.05% |
23,386,712
-2,977,088
| -11% | -$50.8M |
|
305
DexCom
DXCM
$34.1B
| $409M | 0.05% |
2,947,440
-2,552,456
| -46% | -$321M |
|
306
Microchip Technology
MCHP
$43.3B
| $406M | 0.05% |
4,527,709
+673,992
| +17% | +$58.1M |
|
307
Xcel Energy
XEL
$49.4B
| $406M | 0.05% |
7,552,625
+6,684,499
| +770% | +$382M |
|
308
Equifax
EFX
$21.3B
| $405M | 0.05% |
1,514,093
+633,887
| +72% | +$161M |
|
309
Bio-Techne
TECH
$11.3B
| $404M | 0.05% |
5,746,119
+2,755,065
| +92% | +$197M |
|
310
Copart
CPRT
$26.9B
| $397M | 0.05% |
6,861,282
+1,500,466
| +28% | +$77.2M |
|
311
lululemon athletica
LULU
$13.6B
| $396M | 0.05% |
1,013,303
-538,463
| -35% | -$249M |
|
|
SUM
312
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $394M | 0.05% |
8,837,110
+22,840
| +0.3% | +$903K |
|
313
Caterpillar
CAT
$395B
| $392M | 0.05% |
1,070,860
-54,060
| -5% | -$17.3M |
|
314
Celestica
CLS
$45.7B
| $391M | 0.05% |
8,703,742
+8,368,293
| +2,495% | +$318M |
|
315
Burlington
BURL
$22.2B
| $391M | 0.05% |
1,684,245
+12,238
| +0.7% | +$2.5M |
|
316
Loews
L
$23.1B
| $391M | 0.05% |
4,994,021
-164,484
| -3% | -$12.2M |
|
317
Steris
STE
$22.9B
| $391M | 0.05% |
1,738,630
+120,616
| +7% | +$27.2M |
|
318
Vertiv
VRT
$112B
| $390M | 0.05% |
4,777,057
+3,591,903
| +303% | +$226M |
|
319
Kinder Morgan
KMI
$71.1B
| $374M | 0.05% |
20,414,765
-8,109,163
| -28% | -$142M |
|
320
RPM International
RPM
$14.4B
| $368M | 0.05% |
3,095,127
+6,521
| +0.2% | +$725K |
|
321
GE Vernova
GEV
$278B
| $367M | 0.05% |
+2,687,194
| New | +$360M |
|
322
Popular Inc
BPOP
$11.4B
| $361M | 0.04% |
4,099,467
-190,264
| -4% | -$16M |
|
323
Elanco Animal Health
ELAN
$11.3B
| $360M | 0.04% |
22,139,018
+852,281
| +4% | +$13.3M |
|
324
e.l.f. Beauty
ELF
$5.41B
| $360M | 0.04% |
1,837,814
-32,493
| -2% | -$5.77M |
|
325
Charles River Laboratories
CRL
$13.6B
| $358M | 0.04% |
1,322,454
-120,721
| -8% | -$28.8M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.